[1]马素红,李 游,郑维波.桑菊饮加减方治疗感染后咳嗽风热阴伤证临床研究*[J].陕西中医,2019,(3):315-318.
 MA Suhong,LI You,ZHENG Weibo..Clinical effect of Sangju Yin Jiajian in treating postinfection cough Fengre Shangyin syndrome[J].,2019,(3):315-318.
点击复制

桑菊饮加减方治疗感染后咳嗽风热阴伤证临床研究*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2019年3
页码:
315-318
栏目:
临床研究
出版日期:
2019-03-05

文章信息/Info

Title:
Clinical effect of Sangju Yin Jiajian in treating postinfection cough Fengre Shangyin syndrome
文章编号:
DOI: 10.3969/j.issn.10007369.2019.03.012
作者:
马素红1李 游2郑维波1
1.云南中医学院临床医学院眼科教研室(昆明 650051);2.昆明市第二人民医院中医科(昆明 650051);〖JZ〗3.云南省文山州中医医院心肺科(文山 663009)
Author(s):
MA Suhong LI You ZHENG Weibo.
Department of Ophthalmology, School of Clinical Medicine, Yunnan University 〖JZ〗of Traditional Chinese Medicine(Kunming 650051)
关键词:
感染后咳嗽中西医结合疗法风热阴伤证桑菊饮加减方疗效比较研究上呼吸道感染
Keywords:
Key words Cough after infection Combination therapy of traditional Chinese and western medicine Syndrome of Fengre Shangyin injury Sangju YinComparative study on curative effectUpper respiratory tract infection
分类号:
R256.11
文献标志码:
A
摘要:
摘 要 目的:研究探讨桑菊止咳方治疗感染后咳嗽风热阴伤证的临床效果。方法:选择观察期间就诊的90例感染后咳嗽风热阴伤证患者,按照随机数字表法划分为两组,各45例,对照组给予常规西药治疗,观察组在常规西药治疗基础上加用桑菊饮加减方治疗,比较两组的临床疗效、中医证候积分、症状缓解时间、血清炎症因子指标、免疫球蛋白指标、不良反应发生率。结果:观察组的总有效率95.56%高于对照组的80.00%(P<0.05),其咳嗽、咽痒等症状缓解时间(3.98±1.05) d、(2.59±0.62)d均短于对照组的(4.27±1.36)d、(3.46±0.87)d(P<0.05)。治疗后观察组的咳嗽咳痰、胸闷气短、咽痒口干、声音嘶哑等积分(1.37±0.31)分、(1.55±0.36)分、(1.34±0.38)分、(1.36±0.29)分均低于对照组的(1.69±0.35)分、(1.91±0.38)分、(1.78±0.41)分、(1.72±0.37)分(P<0.05),其CRP(5.18±3.09)mg/L、IL6(20.05±2.76)ng/L、TNFα(8.43±2.92)mg/L均低于对照组的(8.50±3.27)mg/L、(23.24±3.07)ng/L、(11.86±3.71)mg/L(P<0.05)。观察组其IgG(11.75±1.34)g/L、IgA(3.09±0.41)g/L、IgM(1.46±0.29)g/L均高于对照组的(10.42±1.17)g/L、(2.68±0.37)g/L、(1.18±0.26)g/L(P<0.05)。观察组与对照组的不良反应总发生率分别为6.67%、4.44%,差异无统计学意义(P>0.05)。结论:在感染后咳嗽风热阴伤证患者西药治疗基础上应用桑菊饮加减方,可有效减轻患者临床症状,抑制其机体内炎症反应,提高其免疫力,且不会增加用药不良反应,兼具良好的临床疗效和安全性。
Abstract:
Abstract Objective: To study the clinical effect of Sangju Yin Jiajian in treating postinfection cough Fengre Shang Yin syndrome. Methods: 90 patients with cough Fengre Shangyin after infection were randomly divided into two groups,45 cases in each group. The control group was treated with routine western medicine. The observation group was treated with Sangju YJiajian on the basis of routine western medicine. The clinical efficacy, TCM syndrome score, symptom remission time, serum inflammatory factor index, immunoglobulin index and adverse reaction rate were compared between the two groups. Results: The total effective rate of the observation group (95.56%) was higher than that of the control group (80.00%) (P<0.05). The relief time of cough, pharynx itch and other symptoms in the observation group (3.98 ±1.05) d and (2.59 ±0.62) d were shorter than that in the control group (4.27 ±1.36) d,(3. 46 ±0. 87) d (P<0. 05). After treatment, the scores of cough and expectoration, shortness of chest, dry pharynx and itching mouth, hoarseness of voice (1.37 ±0.31, 1.55 ±0.36, 1.34 ±0.38, 1.36 ±0.29) in the observation group were lower than those in the control group (1.69 ±0.35,1.91 ±0.38,1.78 ±0.41,1.72±0.37), CRP (5.18 ±3.09) mg/L, IL6 (20.05 ±2.76) ng/L; TNF α (8.43 ±2.92) mg/L was lower than control group (8.50 ±3.27) mg/L, (23.24 ±3.07) ng/L, (11.86 ±3.71) mg/L (P<0.05), and its IgG was (11.75 ±1.34) g / L. IgA (3.09 ±0.41) g / L, IgM (1.46 ±0.29) g / L was significantly higher than that of control group (10.42 ±1.17) g / L, (2.68 ±0.37) g / L, (1.18 ±0.26) g / L (P<0.05). The total 〖LM〗incidence of adverse reactions in the observation group and the control group was 6.67 and 4.44.The difference was not statistically significant (P>0.05). Conclusion: The application of Sangju Yin Jiajian on the basis of western medicine treatment in patients with cough Fengre Shangyin syndrome after infection can effectively alleviate the clinical symptoms of the patients, suppress the inflammatory reaction in the body, improve their immunity, and not increase the adverse drug reactions. Both good clinical efficacy and safety.

参考文献/References:

[1] 王东安,孙洁民,文 芸,等.酮替芬治疗50例感染后咳嗽的疗效观察[J] .重庆医学,2015,44(30):42724273.
[2] 顾倩倩.孟鲁司特用于治疗感染后咳嗽的疗效分析[J] .中国生化药物杂志,2017,37(10):217218.
[3] 胡诣璋,赵 俊,崔 瑷,等.感染后咳嗽发病机制及治疗进展[J] .临床药物治疗杂志,2016,14(1):1116.
[4] Huang J, Luo Q, Tan Q, et al. Evaluation of the surgical fatfilling procedure in the treatment of refractory cough after systematic mediastinal lymphadenectomy in patients with right lung cancer [J] . J Surg Res, 2014,187(2):490495.
[5] 张 艳.止嗽散加减联合抗生素治疗感染后咳嗽疗效观察[J] .现代中西医结合杂志,2015,24(1):5152.
[6] 中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2015)[J] .中华结核和呼吸杂志,2016,39(5):323354.
[7] 国家中医药管理局.中药新药临床研究指导原则(试行)\[M\].北京:中国医药科技出版社,2002.
[8] 陈爱娥,蔡晓平,熊军芳,等.苏黄止咳胶囊治疗感染后咳嗽的疗效及神经源性气道炎症介质的动态变化[J] .实用药物与临床,2016,19(8):981984.
[9] 刘 丽.止嗽散治疗感染后咳嗽随机对照试验分析[J] .中国临床医生杂志,2015,43(9):5153.〖ZK)〗
[10] 陈金寅.沙美特罗替卡松治疗感染后咳嗽的临床疗效观察[J] .中国药师,2016,19(5):945946,947.
[11] Zanasi A, Mazzolini M, Tursi F, et al. Homeopathic medicine for acute cough in upper respiratory tract infections and acute bronchitis: a randomized, doubleblind, placebocontrolled trial [J] . Pulm Pharmacol Ther, 2014,27(1):102108.
[12] 陆月明,王 莉,顾 盼,等.沙美特罗替卡松治疗感染后咳嗽的临床观察[J] .中国医刊,2015,50(2):3638.
[13] 孙远南,陆明荣,倪 慧,等.右美沙芬缓释混悬液联合孟鲁司特钠治疗感染后咳嗽的临床疗效分析[J] .中华医院感染学杂志,2016,26(17):39363938.
[14] Wang K, Birring SS, Taylor K, et al. Montelukast for postinfectious cough in adults: a doubleblind randomised placebocontrolled trial [J] . Lancet Respir Med, 2014,2(1):3543.
[15] 栾小英,尹小平,栾 伟,等.孟鲁司特和布地奈德联合玉屏风颗粒治疗儿童感染后咳嗽疗效分析[J] .湖北中医杂志,2015,37(6):24.
[16] 林诗杰.复方甲氧那明胶囊联合苏黄止咳胶囊治疗成人感染后咳嗽的疗效[J] .实用医学杂志,2017,33(8):13621363.
[17] 姜 燕,刘 昊,毛 兵,等.感染后咳嗽的中医证型分布规律[J] .长春中医药大学学报,2016,32(3):510511.
[18] 肖 磊,冯高华,李宇青,等.自拟祛风宣肺方联合复方甲氧那明治疗感染后咳嗽疗效观察[J] .湖北中医药大学学报,2015,17(6):6768,69.
[19] 赵西斌,李燕宁.桑菊饮合止咳散加减联合阿奇霉素治疗小儿肺炎支原体感染临床观察[J] .新中医,2017,26(9):217-220.
[20] 梁锐中.止嗽散合桑菊饮化裁治疗感冒后咳嗽疗效观察[J] .广西中医药,2017,40(1):5859.
[21] 齐 瑞,张 欢,李瑞婷,等.桑杏汤加味治疗小儿感染后咳嗽51例[J] .陕西中医,2017,38(4):454455.
[22] 秦 阳.桑菊止咳方治疗感染后咳嗽(风热阴伤证)的临床研究\[D\].北京:北京中医药大学,2016.

相似文献/References:

[1]杨禹娟,张勇,吕军,等.益气复脉注射液治疗老年冠心病并发慢性心力衰竭30例[J].陕西中医,2016,(10):1325.
 Yang Yujuan,Zhang Yong,Lv Jun,et al.[J].,2016,(3):1325.
[2]景中民,朱海松,徐海亮,等.前列舒通胶囊联合盐酸坦索罗辛胶囊治疗湿热瘀阻型前列腺炎临床研究*[J].陕西中医,2019,(3):294.
 JING Zhongmin,ZHU Haisong,XU Hailiang,et al.Clinical reserach of Qianlie Shutong capsule combined with tamsulosin hydrochloride capsule in treating dampheat stagnation prostatitis[J].,2019,(3):294.
[3]张 振,郜文辉,王亚琪,等.益气化瘀解毒方加减联合索拉非尼治疗原发性肝癌疗效研究*[J].陕西中医,2019,(3):322.
 ZHANG Zhen,GAO Wenhui,WANG Yaqi,et al.Study on curative effect of Yiqi Huayu Jiedu decoction combined with solafenil in the treatment of primary hepatocellular carcinoma[J].,2019,(3):322.
[4]陈 晨.补阳还五汤对急性脑梗死患者血管内皮生长因子、血管生成素2及神经功能影响的研究*[J].陕西中医,2019,(1):28.
[5]张连生,王月田,张志洋.针刺、西替利嗪联合曲安奈德喷雾剂治疗变应性鼻炎疗效 及对患者RQLQ评分、slgE、血清炎症因子的影响*[J].陕西中医,2019,(4):534.
[6]全 健,丁文涛 Δ,武 辉.穴位注射配合桂枝芍药知母汤加减治疗类风湿性关节炎临床研究[J].陕西中医,2019,(5):671.
 QUAN Jian,DING Wentao,WU Hui..Rheumatoid arthritis treated by acupoint injection combined with Guizhi Shaoyao Zhimu decoction[J].,2019,(3):671.
[7]杨宏升.安胃活血汤联合序贯法治疗慢性萎缩性胃炎胃癌前病变疗效研究[J].陕西中医,2019,(9):1195.
 YANG Hongsheng..Effect of Anwei Huoxue decoction combined with sequential therapy on gastric precancerous lesions of chronic atrophic gastritis[J].,2019,(3):1195.
[8]戴凤翔,邱联群△.当归四逆汤联合灸法治疗类风湿性关节炎临床研究[J].陕西中医,2019,(9):1235.
[9]樵书宏,寇鹏涛,郭娟莉,等.桃红四物汤联合普瑞巴林治疗带状疱疹后遗神经痛疗效及机制研究*[J].陕西中医,2019,(9):1251.
 QIAO Shuhong,KOU Pengtao,GUO Juanli,et al.Efficacy and mechanism of Taohong Siwu decoction combined with pregabalin in the treatment of postherpetic neuralgia[J].,2019,(3):1251.
[10]位式祥,于会勇,聂天旸,等.名中医王成祥基于“体病相关-体质可调”理论治疗感染后咳嗽经验[J].陕西中医,2025,46(4):545.[doi:DOI:10.3969/j.issn.1000-7369.2025.04.024]

备注/Memo

备注/Memo:
*〖JP5〗昆明市卫生科技人才培养暨“十百千”工程基金资助项目\[SW(市)02\]
更新日期/Last Update: 2019-03-13